MEDIFAST INC

MED Consumer Cyclical Personal Services

MEDIFAST INC’s revenue for fiscal 2025 (year ended December 2025) was $385.8 million, down 36.0% from fiscal 2024. In the quarter to June 2026, revenue fell 27.6%, EPS fell 221.7% and free cash flow grew 115.3%, each against the same quarter a year earlier. Dividend growth for five consecutive years; insiders bought in the last twelve months.

11.88 0.18 −1.49%
Market cap
$134.8M
P/E
0.0×
Fwd P/E
−7.4×
Dividend yield
—
F-score
4/9
Altman Z
4.46
Beneish M
n/a
Dividend safety
57/100
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
27.82 31.12 26.83 16.55 22.46 14.95 9.00 7.69 97.89 0.00
Piotroski F-Score
7 6 7 7 8 6 5 7 6 4
P/S ratio
1.81 2.87 2.98 1.81 2.47 1.61 0.81 0.71 0.32 0.30
Altman Z-Score
16.57 18.06 20.85 15.50 17.98 14.21 12.72 10.15 5.22 4.46
Altman Z″-Score (non-manufacturers)
12.16 11.15 10.46 9.71 9.40 8.55 8.08 9.32 8.54 10.15
P/FCF ratio
0.00 65.95 51.31 27.31 20.57 73.46 8.54 6.69 0.00 0.00
P/Operating CF
(1,579.31) 86.61 97.38 67.35 116.55 (328.65) 24.90 72.65 (38.93) (22.22)
Beneish M-Score
(3.05) 0.35 (1.83) (1.46) — — — — — —
Dividend Safety Score
— — — — — — — — — 57
P/B ratio
5.18 7.96 13.69 12.30 14.70 12.11 8.31 3.79 0.92 0.59
Price to Tangible BV
5.18 7.96 13.69 12.30 14.70 12.11 8.31 3.79 0.92 0.59
EV/Sales
1.53 2.54 2.78 1.70 2.30 1.56 0.78 0.61 0.11 (0.03)
EV/EBITDA
12.87 17.20 18.81 12.60 15.47 10.64 6.37 4.72 4.65 17.88
EV/Operating CF
16.60 17.72 22.90 14.37 14.79 25.11 6.41 4.45 2.81 (1.67)
EV/FCF
(110.33) 58.43 47.85 25.63 19.12 71.15 8.27 5.76 (6.92) 0.45
Quick Ratio
3.20 2.68 1.69 1.19 1.57 0.65 0.62 1.63 2.53 3.89
Current Ratio
4.15 3.37 2.41 1.94 2.10 1.81 1.58 2.43 3.34 4.69
Net Debt/EBITDA
(2.35) (2.22) (1.36) (0.96) (1.26) (0.49) (0.45) (1.08) (10.98) 260.55
Debt/Assets
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt/Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Asset Turnover
2.31 2.26 3.18 3.92 3.97 4.53 4.47 3.42 2.03 1.45
Operating CF/Net income
1.42 1.56 1.09 1.08 1.41 0.58 1.36 1.49 11.71 (0.37)
Capex/Depreciation
(4.93) (0.64) (0.95) (1.98) (1.27) (4.96) (1.52) (0.50) (0.63) (0.41)
Interest Coverage
94.91 39.63 69.06 91.04 (545.36) 936.11 263.63 — — —
ROE
19.32% 27.10% 51.26% 72.84% 78.49% 91.20% 80.31% 55.77% 1.02% (9.13%)
ROA
15.03% 20.75% 35.38% 42.80% 43.70% 48.64% 40.18% 31.76% 0.70% (7.02%)
ROIC
87.58% 254.13% 534.74% 468.15% 0.00% 145.43% 171.49% 153.58% 3.77% (28.07%)
Return on Tangible Assets
18.46% 25.99% 53.16% 77.30% 68.30% 84.92% 103.23% 54.27% 1.11% (9.83%)
Average Days of Receivables
1.84 0.70 0.74 0.73 0.00 0.00 0.00 0.00 0.00 0.00
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
65.13% 62.40% 62.04% 62.47% 60.29% 59.72% 59.78% 60.58% 73.32% 75.02%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
1.25% 1.41% 0.62% 0.63% 0.73% 0.65% 0.69% 0.76% 1.22% 1.98%
Graham Net Nets
0.15 0.10 0.06 0.05 0.05 0.05 0.05 0.15 0.73 1.30
Graham Number
16.60 21.85 30.94 36.42 51.25 73.84 63.13 61.67 8.82 0.00
Earnings Yield
3.59% 3.21% 3.73% 6.04% 4.45% 6.69% 11.11% 13.00% 1.02% (15.92%)
Free Cash Flow Yield
(0.77%) 1.52% 1.95% 3.66% 4.86% 1.36% 11.71% 14.94% (5.16%) (21.93%)
Revenue per Share
23.18 25.29 41.94 60.63 79.42 130.38 142.79 98.50 55.12 35.13
Operating CF per Share
2.14 3.63 5.09 7.16 12.34 8.08 17.38 13.57 2.24 0.63
Capex per Share
(2.43) (0.27) (0.40) (0.85) (0.50) (2.92) (1.49) (0.60) (0.68) (0.51)
Free Cash Flow per Share
(0.29) 3.36 4.69 6.30 11.83 5.15 15.89 12.97 1.56 0.11
Cash per Share
6.49 8.29 8.46 7.87 14.82 9.36 7.83 13.79 14.85 15.23
Shareholders Equity per Share
8.11 9.11 9.13 8.91 13.36 17.30 13.85 18.51 19.22 18.11
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
8.11 9.11 9.13 8.91 13.36 17.30 13.85 18.51 19.22 18.11
Free Cash Flow
(3.43) 40.08 56.07 74.20 139.31 60.34 177.89 141.17 17.02 1.25
Working Capital
76.88 88.06 85.20 74.76 122.96 137.03 81.89 131.73 150.24 158.72
Capital Expenditures
(28.78) (3.16) (4.74) (10.06) (5.89) (34.21) (16.68) (6.48) (7.45) (5.61)
Net Current Asset Value
76.10 87.85 85.20 64.33 115.48 111.01 61.62 115.60 140.30 152.63
EV/EBIT
15.67 19.33 20.17 13.30 16.01 10.98 6.75 5.20 23.89 0.81
Capex to Sales
0.10 0.01 0.01 0.01 0.01 0.02 0.01 0.01 0.01 0.01
Price to Operating Income
18.52 21.82 21.63 14.17 17.23 11.34 6.97 6.05 66.92 0.00
Other line items
Depreciation/Fixed assets
0.30 0.26 0.25 0.20 0.17 0.12 0.19 0.25 0.32 0.43
Cash ROIC
(1.98%) 19.32% 26.68% 37.57% 42.00% 19.34% 73.29% 40.16% 4.57% 0.34%
Accounts Receivable Turnover
181.81 307.25 631.38 583.07 925.13 0.00 0.00 0.00 0.00 0.00
Accounts Payable Turnover
2.94 2.40 2.49 2.59 2.58 2.94 3.07 2.68 2.21 2.33
Inventory Turnover
4.35 3.92 4.16 4.03 4.64 3.41 3.07 3.42 3.25 3.53
Average Days of Payables
128.79 183.81 181.81 157.34 165.81 149.58 107.30 106.49 130.64 126.59
Days of Inventory on Hand
97.05 95.66 117.21 100.68 82.22 164.91 94.69 67.27 98.10 66.76
Average Receivables
1.51 0.98 0.79 1.22 1.01 — — — — —
Average Payables
23.40 30.72 48.73 68.27 91.95 135.49 149.00 110.55 71.45 47.43
Average Inventory
15.82 18.82 29.11 43.83 51.08 116.72 149.45 86.72 48.51 31.32
Average Assets
118.67 133.57 157.68 182.04 235.37 337.21 357.27 313.06 297.06 266.09
Average Common Equity
92.30 102.30 108.84 106.97 131.04 179.86 178.76 178.26 205.80 204.51

Fold the line items

Columns are period end dates